Answers are grounded in this paper and cite their sources.
A Wnt-binding site of the WIF-domain of Wnt inhibitory factor-1 was localized by structure-guided arginine-scanning mutagenesis in combination with surface plasmon resonance assays. Our observation that substitution of some residues of WIF resulted in an increased affinity for Wnt5a, but decreased affinity for Wnt3a, suggests that these residues may define the specificity spectrum of WIF for Wnts. These results hold promise for a more specific targeting of Wnt family members with WIF variants in various forms of cancer.
No takes yet. Share an insight, caveat, or question.
Bányai et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: